Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Chem ; 56(12): 1854-61, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20940330

RESUMO

BACKGROUND: We sought to develop a tandem mass spectrometry assay in which the enzymatic activities of 3 lysosomal enzymes (α-glucosidase, α-galactosidase A, and α-l-iduronidase) could be quantified in dried blood spots by using a single assay buffer. METHODS: A 3-mm dried blood spot punch was incubated in a single assay buffer with 3 different substrates and internal standards. The sample was processed by a simple liquid-liquid extraction by using ethyl acetate. The extract was dried down and resuspended in solvent for injection into the tandem mass spectrometer. Products and internal standards were monitored by multiple reaction monitoring. RESULTS: Assay for the 3 lysosomal enzymes was successfully achieved with acceptable statistics. The assay can be performed by using a minimal quantity of disposable supplies and equipment. The entire procedure fits into a 48-h cycle including data analysis. Data from 5990 anonymous newborn dried blood spots showed an approximate bell-shaped distribution of enzymatic activities (mean values of 19.0, 11.5, and 3.5 µmol · h(-1) · (L blood)(-1) for α-glucosidase, α-galactosidase A, and α-l-iduronidase, respectively. Blank values obtained in the absence of blood were 0.13, 0.24, and 0.45 µmol · h(-1) · (L blood)(-1), respectively). By assaying 3 enzymes at once, problematic samples are spotted for reanalysis if enzyme activity values are low for all enzymes (for example, if insufficient blood is present in the assay). CONCLUSIONS: This method demonstrates that a triplex assay in a single buffer and with minimal supplies and labor can be adapted to a high-throughput newborn screening laboratory for the analysis of Pompe, Fabry, and mucopolysaccharidosis-I (Hurler) diseases.


Assuntos
Doença de Fabry/diagnóstico , Doença de Depósito de Glicogênio Tipo II/diagnóstico , Iduronidase/sangue , Mucopolissacaridose I/diagnóstico , alfa-Galactosidase/sangue , alfa-Glucosidases/sangue , Adulto , Soluções Tampão , Doença de Fabry/sangue , Doença de Depósito de Glicogênio Tipo II/sangue , Humanos , Concentração de Íons de Hidrogênio , Lactente , Recém-Nascido , Masculino , Mucopolissacaridose I/sangue , Triagem Neonatal , Espectrometria de Massas por Ionização por Electrospray , Espectrometria de Massas em Tandem
2.
J Med Chem ; 46(1): 190-3, 2003 Jan 02.
Artigo em Inglês | MEDLINE | ID: mdl-12502373

RESUMO

Poly-alpha-(l-glutamic acid) (PG) conjugates of 20(S)-camptothecin (1, CPT) displayed improved aqueous solubility compared to CPT, were stable in aqueous solution at neutral pH, and were potent antitumor agents in vivo. Evaluation of PG molecular weight, CPT loading, aqueous solubility, and CPT equivalent dosing with respect to in vivo antitumor potencies of various linked conjugates led to identification of a preferred conjugate composition.


Assuntos
Antineoplásicos/síntese química , Camptotecina/análogos & derivados , Camptotecina/síntese química , Ácido Poliglutâmico/análogos & derivados , Ácido Poliglutâmico/síntese química , Animais , Antineoplásicos/farmacologia , Camptotecina/farmacologia , Estabilidade de Medicamentos , Concentração de Íons de Hidrogênio , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Nus , Ácido Poliglutâmico/farmacologia , Soluções , Relação Estrutura-Atividade , Ensaios Antitumorais Modelo de Xenoenxerto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA